unaudited consolidated financial results for the quarter ended
The announcement will be followed by a conference call and webcast with
update and review second quarter financial results.
To access the conference call via telephone, please dial (877) 412-6083
telephone replay will be available from approximately
conference call, dial (855) 859-2056 from
537-3406 for international access. The pass code for the live call and
the replay is 10874179.
The call will be webcast with slides and accessible through the
Investors section of the company’s website at www.amagpharma.com.
The webcast replay will be available from approximately 11:00 a.m.
development and commercialization of a therapeutic iron compound to
treat iron deficiency anemia. AMAG manufactures and sells Feraheme®
(ferumoxytol) Injection for intravenous use. For additional company or
product information, please visit www.amagpharma.com
Feraheme is a registered trademark of
AMAG Pharmaceuticals, Inc.
Amy Sullivan, 617-498-3303